Llevo dos meses utilizando el ASUS ProArt GoPro Edition PX13 para editar vídeos y trabajar con contenido audiovisual, y tengo ...

(*) Seleccionamos de forma independiente todos los productos y servicios. Si hace clic en los enlaces que propo ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Editas Medicine (EDIT) traded higher on Thursday after Australian authorities cleared a Phase 1/2 trial for the company’s gene-editing therapy EDIT-401, and Wells Fargo upgraded the biotech to ...

The last time I spoke about Editas Medicine (EDIT) it was with a Seeking Alpha article entitled "Editas Medicine: Several Catalysts For Reni-Cel In 2024 Make This A Must Watch." With respect to this ...

To access the live webcast of Editas Medicine’s Fireside Chat, please visit the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for ...

Fintel reports that on October 8, 2026, Wells Fargo upgraded their outlook for Editas Medicine (NASDAQGS:EDIT) (LSE:0IFK) from Equal-Weight to Overweight. Editas Medicine, Inc., based in the United ...

While action cameras can shoot anywhere, they’re not known for producing movie theater-quality footage. The GoPro Mission 1 PRO ILS shatters that silver ceiling. Designed with input solicited on the ...

Wells Fargo analyst Yanan Zhu upgrades Editas Medicine (NASDAQ:EDIT) from Equal-Weight to Overweight and raises the price target from $4 to $6. Guggenheim analyst Debjit Chattopadhyay upgrades Editas ...

Phase 1/2 clinical trial of EDIT-401 cleared to initiate dosing in patients who require additional LDL-C lowering Company remains on track to begin patient dosing this year and report initial safety ...